Maryland Tech Council’s Post

A statement from Kelly Schulz on the Federal Trade Commission’s Hart-Scott-Rodino (HSR) pre-merger notification rules, and how they risk hampering Maryland’s technology and life sciences ecosystem. “As the largest technology and life sciences association in Maryland, we are concerned about the implications of the final HSR rules as issued by the Federal Trade Commission. The final rule will chill mergers and acquisitions (M&A) and hamper Maryland’s technology and life sciences industries, which employ more than 300,000 Marylanders and generate billions of dollars in economic activity in our state. Above all, we believe in saving lives, securing our nation, and improving quality of life through innovation, and restricting M&A threatens to upend industry’s ability to do so. We ask that our federal representatives support balanced and bipartisan policies that enable pro-competition, pro-innovation M&A.” #FTC #lifesciences #HSR PULSE (Partnership for the US Life Science Ecosystem)

Kicking off an incredible day at the Bio Innovation Conference! From groundbreaking research to life-changing innovations, Maryland’s life sciences community is leading the charge. Excited to see what’s next for our thriving ecosystem. Follow along @MDTechCouncil on X for live updates and highlights of the day. Let’s make today one to remember! #MDLSBioInnovation

Behind the scenes setting up for the 2024 Bio Innovation Conference! We are thrilled to welcome attendees tomorrow. #MDLSBioInnovation Make sure to stop by our exhibit booth to pack community bags for Canine Warrior Connections with BioHub Maryland.

Behind the scenes setting up for the 2024 Bio Innovation Conference! We are thrilled to welcome attendees tomorrow. #MDLSBioInnovation Make sure to stop by our exhibit booth to pack community bags for Canine Warrior Connections with BioHub Maryland.

In cased you missed it, we are thrilled to announce that BioHub Maryland has secured a $75,000 EARN Maryland grant from the Maryland Department of Labor to train Marylanders for biopharma manufacturing careers. The life sciences sector is a major driver of Maryland's economy, with 54,000 workers in Maryland. With a national shortage of biopharma talent, we have a clear opportunity to enhance Maryland’s competitive edge by reskilling current employees and upskilling newcomers. We are grateful for the Moore-Miller Administration's support in developing the highly-skilled talent pipeline industry needs to succeed in Maryland. Read more: https://lnkd.in/efpG6VhC

MTC and Fisher Scientific are working together to give you access to the unequaled catalog of laboratory supplies, as well as customer support and competitive pricing to help stretch your budget and enable your science. Learn more on MTCEdge: https://bit.ly/3VKZMyH Fisher Scientific

Excited for the Bio Innovation Conference this Thursday! Registration is now closed, but stay tuned for updates and highlights from the event. https://lnkd.in/eiyzpzCM #MDLSbioinnovation #conference #lifesciences

The Maryland Tech Council is proud to support the launch of #CyberTalentNow—an incredible, first-of-its-kind security training sprint offering cost-free training to 10,000 Maryland IT professionals! Learn more and apply here: https://lnkd.in/ePba_WPB Full statement: https://lnkd.in/evxXmxSC

🚨 Last Chance to Register! https://lnkd.in/dXWG8mD Join us at the 2024 Bio Innovation Conference on October 10th for a deep dive into Expedited FDA Approval and Expanded Access Tools: Getting Products to Patients. Don't miss this expert panel featuring top leaders in regulatory affairs, sharing key strategies on fast-tracking life-saving treatments: Panelists: Renee Beaver, Director of Corporate Counsel, Otsuka Pharmaceutical Companies (U.S.) Jacqueline Corrigan-Curay, Principal, FDA’s Center for Drug Evaluation and Research (CDER) Michael Matthews, Director of Regulatory Affairs, Sabin Vaccine Institute Melissa Robb, Senior Director Regulatory Strategy, REGENXBIO Moderator: Justin Coen, Partner, Venable LLP Gain insights on leveraging FDA approval mechanisms like fast track, breakthrough therapy, and expanded access INDs to increase patient access. #BioInnovation2024 #FDA #LifeSciences #RegulatoryAffairs #FastTrack

Today is your LAST chance to register for the Bio Innovation Conference on October 10th! Don't miss out on networking through BIO Partnering, hearing from industry leaders, meeting innovative exhibitors, and more. Secure your spot now! https://lnkd.in/eAJRXY7C